Clinical Trials Browser

Phase 2 × Completed × necitumumab × Clear all

NCT02392507 2020-11-19

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Phase 2 Completed

54 enrolled 16 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT01606748 2019-09-30

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

Phase 2 Completed

35 enrolled 23 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01769391 2019-09-20

A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer

Phase 2 Completed

167 enrolled 17 charts

Squamous Non Small Cell Lung Cancer

NCT01624467 2016-07-25

A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

Phase 2 Completed

75 enrolled 12 charts

Other solid neoplasm

Solid Tumors

NCT01788566 2016-06-27

A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer

Phase 2 Completed

61 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT00835185 2016-01-29

Study of IMC-11F8 in Participants With Colorectal Cancer

Phase 2 Completed

44 enrolled 20 charts

Gastrointestinal

Colorectal Neoplasms